Cited by 233Genetic Associations and EpidemiologyTryptophan and brain disordersTreatment of Major Depression

Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations

Open access
Milaneschi, Yuri, Lamers, Femke, Peyrot, Wouter J., Baune, Bernhard T., Breen, Gerome, Dehghan, Abbas, Forstner, Andreas J., Grabe, Hans J. +17 more·2017·JAMA Psychiatry

Abstract

Importance: The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. Objective: To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). Design, Setting, and Patients: This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. Main Outcomes and Measures: Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased. Results: Data included 11 837 participants with MDD and 14 791 control individuals, for a total of 26 628 participants (59.1% female and 40.9% male). Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation (SE) with BMI (0.53 [0.15]; P = 6.3 × 10-4), whereas the decreased A/W subgroup showed an inverse correlation (-0.28 [0.14]; P = .06). Furthermore, the decreased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18; 95% CI, 1.12-1.25; P = 1.6 × 10-10) and levels of CRP (OR, 1.08; 95% CI, 1.02-1.13; P = 7.3 × 10-3) and leptin (OR, 1.09; 95% CI, 1.06-1.12; P = 1.7 × 10-3). Conclusions and Relevance: The phenotypic associations between atypical depressive symptoms and obesity-related traits may arise from shared pathophysiologic mechanisms in patients with MDD. Development of treatments effectively targeting immunometabolic dysregulations may benefit patients with depression and obesity, both syndromes with important disability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2017.3016

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obese individuals, particularly those presenting attributes of metabolic syndrome, tend to develop the atypical subtype of depression.

    “Obese individuals, particularly those presenting attributes of metabolic syndrome (abdominal obesity, hyperglycemia, hypertension, elevated triglycerides), tend to develop the atypical subtype [9] (Box 1).”

    From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [9]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Milaneschi, Y., Lamers, F., Peyrot, W. J., Baune, B. T., Breen, G., Dehghan, A., Forstner, A. J., Grabe, H. J., Homuth, G., Kan, C., Lewis, C., Mullins, N., Nauck, M., Pistis, G., Preisig, M., Rivera, M., Rietschel, M., Streit, F., Strohmaier, J., Teumer, A., Van der Auwera, S., Wray, N. R., Boomsma, D. I., Penninx, B. W. J. H., & for the CHARGE Inflammation Working Group and the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Affiliations
  • Amsterdam Neuroscience (NL)
  • The University of Adelaide (AU)
  • King's College London (GB)
  • Imperial College London (GB)
  • University of Bonn (DE)
  • Universitätsmedizin Greifswald (DE)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Universidad de Granada (ES)
  • Heidelberg University (DE)
  • Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
  • The University of Queensland (AU)
  • Vrije Universiteit Amsterdam (NL)
Corresponding author
Milaneschi, Yuri
Venue
JAMA Psychiatry
Published
2017-12-01
Volume
74
Issue
12
Pages
1214
ISSN
2168-622X (ISSN-L)
OpenAlex
W2766503838
Cited by
233
References
56
Citations by year
2026: 15 · 2025: 30 · 2024: 15 · 2023: 29 · 2022: 33 · 2021: 41 · 2020: 31 · 2019: 29 · 2018: 9 · 2017: 1
FWCI
12.71
Type
journal article
Language
en
Open access
Locations
  • JAMA Psychiatry (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • ResearchOnline - JCU (James Cook University) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS (submittedVersion)
  • Iris (University of Trento) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • National Science Foundation (33CS30-139468, 33CS30-148401, 33CSCO-122661)
  • Foundation for the National Institutes of Health (1RC2 MH089995)
  • Amgen
  • Pfizer
  • GlaxoSmithKline (3200B0–105993, 33CSCO-122661, 3200B0-118308, 33CS30-148401, 33CS30-139468)
  • Brigham and Women's Hospital
  • Massachusetts General Hospital
  • University of Southern California
  • Kaiser Permanente
  • Massachusetts Institute of Technology
  • Emory University
  • F. Hoffmann-La Roche
  • Washington University in St. Louis
  • Aarhus Universitet
  • Aarhus Universitetshospital
  • Johns Hopkins University
  • University of Texas Southwestern Medical Center
  • Universität Basel
  • Virginia Commonwealth University
  • South London and Maudsley NHS Foundation Trust
  • Wellcome Trust (104036/Z/14/Z)
  • QIMR Berghofer Medical Research Institute
  • Broad Institute
  • Universitätsmedizin Göttingen
  • National Institute for Health and Care Research (CL-2017-17-003)
  • King's College London
  • University College London
  • University of Oxford
  • Newcastle University
  • European Commission (QLG2-CT-2002-01254, LSHB-CT-2003–503428, 503428, 230374, 01ZZ0103, 01ZZ0403, 01254, 03ZIK012, 01ZZ9603, 334065, LSHB-CT-2003)
  • University of Glasgow
  • Cardiff University
  • Trinity College Dublin
  • Deutsche Forschungsgemeinschaft (Gr1912/5‐1, 01ZZ0403, 01ZZ9603, 03ZIK012, 01ZZ0103)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (148401, 122661, 33CSCO, 118308, 105993, 230374, 3200B0, 33CS30, 139468)
  • Universiteit Leiden (10‐000‐1002)
  • Rijksuniversiteit Groningen (10‐000‐1002)
  • Stiftelsen för Strategisk Forskning
  • James Cook University
  • Queensland University of Technology
  • University of Queensland
  • ZonMw (Middelgroot‐911‐09‐032, 56-464-14192, 184.021.007, 911‐09‐032, 1RC2 MH089995, 10‐000‐1002)
  • Vrije Universiteit Amsterdam (2008.024)
  • Bundesministerium für Bildung und Forschung (01ZZ9603, 01ZZ0103, and 01ZZ0403, 01ZX1314G, 01GS08147, 03ZIK012, 01ZZ0403, and 01ZZ0403, 01ZX1314D, 01GS08144, 01ZZ0103, 01ZX1314A, 01ZZ9603)
  • Albert-Ludwigs-Universität Freiburg
  • Gentofte Hospital
  • Dalhousie University
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (184021007, 10-000-1002, 56‐464‐14192, Spinozapremie 56-464-14192)
  • GGZ inGeest
  • Rivierduinen
  • GGZ Friesland
  • GGZ Drenthe
  • Nederlands Instituut voor Onderzoek van de Gezondheidszorg (10-000-1002)
  • Lundbeckfonden
  • University of Toronto
  • Università degli Studi di Trento
  • Karolinska Institutet
  • Novo Nordisk
  • Vetenskapsrådet (M-2005-1112)
  • Westfälische Wilhelms-Universität Münster
  • Leids Universitair Medisch Centrum
  • Universitair Medisch Centrum Groningen
  • Rigshospitalet
  • Region Hovedstaden
  • Háskóli Íslands
  • Dokuz Eylül Üniversitesi
  • Universidad de Granada
  • Tartu Ülikool
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Chinese Society of Clinical Oncology
  • Siemens Healthineers (01ZZ0103, 01ZZ0403, 01ZZ9603)
  • H. Lundbeck A/S
  • Centre for Cognitive Ageing and Cognitive Epidemiology
  • Universität Greifswald
  • Ministry of Cultural Affairs
  • National Institutes of Health (184.021.007, 389875, EU/QLRT-2001-01254, 1s10od018164-01, 1r01mh081802-01, MH66206, N01MH90003, AA13321, MH059542, AA13320, MH059541, DA12854)
  • School of Medicine, Emory University
  • University of North Carolina at Chapel Hill
  • University of California, San Diego
  • McDonnell Center for Systems Neuroscience
  • Stanley Center for Psychiatric Research, Broad Institute
  • Department of Psychiatry, University of Toronto
  • Medical Research Council (G0701420, MR/K026992/1)
  • Australian Research Council (FT0991360, FT0991022, 389875, QLG2-CT-2002-01254)
  • Queensland Brain Institute
  • Institute of Molecular and Cell Biology
  • Statens Serum Institut
  • Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
  • National Institute on Alcohol Abuse and Alcoholism (R01AA014041, R01AA007535)
  • National Institute of Mental Health (MH66206, MH068457, N01‐MH‐90003, U01MH109528, MH-081802, RC2MH089995, MH089951, MH109532, U24MH068457, MH085520, R01MH060912, U01MH109532, R01MH059552, RC2MH089951, R01MH061686, MH089995, R01MH080403)
  • National Institute on Drug Abuse (K08DA019951)
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK066134)
  • Janssen Research and Development
  • Institute of Genetics
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute
  • NHLBI Division of Intramural Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
major depressive disorder, atypical depression, obesity, genetic correlation, body mass index, C-reactive protein, leptin, polygenic risk, genetic overlap, Psychiatric Genomics Consortium, heritability
MeSH terms
Adult, C-Reactive Protein, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, International Cooperation, Male, Obesity, Psychiatric Status Rating Scales, Weight Gain, Body Mass Index, Genetic Predisposition to Disease, Diagnostic and Statistical Manual of Mental Disorders, Genome-Wide Association Study, Craving

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review